drugset / Trial / NCT03288428

Analgesia Comparison of Nalbuphine and Morphine for Laparoscopic Myomectomy

NCT03288428

Phase 4 Completed 80 enrolled Peking University First Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

to compare the analgesia and side effect of nalbuphine and morphine for elective Laparoscopic myomectomy.

Timeline

Start
2017-05-01
Primary completion
2018-12-31
Completion
2018-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified 60 mg
Subject Nalbuphine Small molecule 30 mg

Indications

No indication recorded.